Product Name
BTB/POZ domain containing protein 9 (BTBD9), ELISA Kit
Full Product Name
Human BTB/POZ domain containing protein 9 (BTBD9) ELISA Kit
Product Gene Name
BTBD9 elisa kit
[Similar Products]
Research Use Only
For Research Use Only. Not for use in diagnostic procedures.
Request for Current Manual Insert
Request Current Manual
Samples
Serum, plasma, Cell Culture Supernatants, body fluid and tissue homogenate
Detection Range
0.5-10ng/mL
Preparation and Storage
Store all reagents at 2-8 degree C.
Sample Preparation
We suggest pre-experimenting with neat (undiluted) samples, 1:2 or 1:4 dilutions. Please avoid diluting your samples more than 1:10 as it would exceed the dilution limit set for this kit. If the expected concentration of the target is beyond the detection range of the kit, please contact our technical support team
Product Note
Select online data sheet information is drawn from bioinformatics databases, occasionally resulting in ambiguous or non-relevant product information. It is the responsibility of the customer to review, verify, and evaluate the information to make sure it matches their requirements before purchasing the kit. Our ELISA Kit assays are dynamic research tools and sometimes they may be updated and improved. If the format of this assay is important to you then please request the current manual or contact our technical support team with a presales inquiry before placing an order. We will confirm the current details of the assay. We cannot guarantee the sample manual posted online is the most current manual.
Other Notes
Small volumes of BTBD9 elisa kit vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.
Searchable Terms for BTBD9 purchase
MBS7244820 is a ready-to-use microwell, strip plate ELISA (enzyme-linked immunosorbent assay) Kit for analyzing the presence of the BTB/POZ domain containing protein 9 (BTBD9) ELISA Kit target analytes in
biological samples. The concentration gradients of the kit standards or positive controls render a theoretical kit detection range in biological research samples containing BTBD9. The ELISA analytical biochemical technique of the MBS7244820 kit is based on BTBD9 antibody-BTBD9 antigen interactions (immunosorbency) and an HRP colorimetric detection system to detect BTBD9 antigen targets in samples. The ELISA Kit is designed to detect native, not recombinant, BTBD9. Appropriate sample types may include undiluted body fluids and/or tissue homogenates, secretions. Quality control assays assessing reproducibility identified the intra-assay CV (%) and inter-assay CV(%).
Product Categories/Family for BTBD9 elisa kit
Signal Transduction
NCBI/Uniprot data below describe general gene information for BTBD9. It may not necessarily be applicable to this product.
NCBI Accession #
NP_001165889.1
[Other Products]
NCBI GenBank Nucleotide #
NM_001172418.1
[Other Products]
UniProt Secondary Accession #
Q494V9; Q494W1; Q96M00[Other Products]
UniProt Related Accession #
Q96Q07[Other Products]
Molecular Weight
61,558 Da
NCBI Official Full Name
BTB/POZ domain-containing protein 9 isoform c
NCBI Official Synonym Full Names
BTB (POZ) domain containing 9
NCBI Official Symbol
BTBD9 [Similar Products]
NCBI Official Synonym Symbols
dJ322I12.1
[Similar Products]
NCBI Protein Information
BTB/POZ domain-containing protein 9
UniProt Protein Name
BTB/POZ domain-containing protein 9
Protein Family
BTB/POZ domain-containing protein
UniProt Gene Name
BTBD9 [Similar Products]
UniProt Synonym Gene Names
KIAA1880 [Similar Products]
UniProt Entry Name
BTBD9_HUMAN
NCBI Summary for BTBD9
This locus encodes a BTB/POZ domain-containing protein. This domain is known to be involved in protein-protein interactions. Polymorphisms at this locus have been reported to be associated with susceptibility to Restless Legs Syndrome and may also be associated with Tourette Syndrome. Alternatively spliced transcript variants have been described. [provided by RefSeq, Aug 2011]
UniProt Comments for BTBD9
BTBD9: Genetic variations in BTBD9 may be associated with susceptibility to restless legs syndrome type 6 (RLS6); also called periodic limb movements in sleep. Restless legs syndrome (RLS) is a neurologic disorder characterized by an uncontrollable urge to move the legs during periods of rest. The majority of patients with RLS also have periodic limb movements in sleep, which are characterized by involuntary, highly stereotypical, regularly occurring limb movements that occur during sleep. 3 isoforms of the human protein are produced by alternative splicing.
Protein type: Unknown function
Chromosomal Location of Human Ortholog: 6p21
Biological Process: circadian sleep/wake cycle, non-REM sleep; long-term memory; ***** locomotory behavior; sensory perception of temperature stimulus; serotonin metabolic process
Disease: Restless Legs Syndrome, Susceptibility To, 6
Research Articles on BTBD9
1. The BTBD9 gene is associated with symptoms of antipsychotic-induced restless legs syndrome in schizophrenia.
Precautions
All of MyBioSource's Products are for scientific laboratory research purposes and are not for diagnostic, therapeutics, prophylactic or in vivo use. Through your purchase, you expressly represent and warrant to MyBioSource that you will properly test and use any Products purchased from MyBioSource in accordance with industry standards. MyBioSource and its authorized distributors reserve the right to refuse to process any order where we reasonably believe that the intended use will fall outside of our acceptable guidelines.
Disclaimer
While every efforts were made to ensure the accuracy of the information provided in this datasheet, MyBioSource will not be liable for any omissions or errors contained herein. MyBioSource reserves the right to make changes to this datasheet at any time without prior notice.
It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.